• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·7779.T
Share

CYBERDYNE Inc. Stocks

¥ 277Last Updated 12.06.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

¥ 241.90M

¥ 277
Key Takeaways

Risk factor

Significant default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense sectors within Japan. Their innovative product line features the Hybrid Assistive Limb (HAL), available in medical variants for lower limbs and single joints, as well as non-medical versions designed for lower limbs, single joints, and lumbar support. The company also supplies HAL peripherals, robotic cleaners, and autonomous transport robots for factories, offices, and various other indoor environments. A notable technological offering is Acoustic X, a high-speed light pulse LED array that facilitates real-time photoacoustic imaging. Complementing their hardware, CYBERDYNE provides specialized treatments and programs such as Cybernics Treatment, which utilizes HAL to restore or enhance function for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disorders. They additionally offer HAL FIT and Neuro HALFIT to improve brain-nerve-musculoskeletal and general physical functions, respectively, and MTX Neuro HAL Plus to optimize brain-nerve performance in athletes. Furthermore, the company extends its expertise to critical areas including disaster rescue operations, heavy industrial labor assistance, and contributions to the entertainment industry.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, overvalued on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 7779.T is 288 and suggests 7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026